[ad_1]
The Emerade 300 and 500 microgram auto-injector pens, which are used to treat anaphylaxis, have been recalled by regulators.
These pens are prescribed to those with life-threatening allergies. However, the Medicines and Healthcare products Regulatory Agency (MHRA) have called on users to swap the brand for another.
Other brands include Epidpen and Jext with patients also being advised to seek help on how to use these as well.
All Emerade 300 and 500 adrenaline pens are being withdrawn.
Contact your GP for a new prescription as soon as possible.
More info https://t.co/vEDOEwpIuq pic.twitter.com/JBkmsjy2VS
— MHRAgovuk (@MHRAgovuk) May 9, 2023
Patients have been told to return their Emerade pens only once they have been given a replacement as a recall is issued.
Current estimates state that around 25,000 people may have one in need of replacement.
Similar concerns have been raised about Emerade products in the past.
Dr Alison Cave, MHRA chief safety officer, said: “Patient safety is our top priority. We are taking prompt action to protect patients, following detection of damage to internal components of the Emerade pens if they are dropped, which may mean they activate too early or fail to activate and deliver adrenaline.
“Patients are reminded to carry two pens with them at all khbrknews as normal and to contact their healthcare professional when a replacement is due.”
We’re making it quicker & easier for you to get the care you need from your GP practice & local pharmacy
Our plan includes:
tackling the 8am rush with better phone & online systems
pharmacies supplying medicines for more conditions
more staff & more appointments pic.twitter.com/UVlEDeE6G6— Department of Health and Social Care (@DHSCgovuk) May 9, 2023
What are the main causes of anaphylaxis?
The most widely reported triggers for anaphylaxis are, according to the NHS, insect bites (usually wasps or bees),…
[ad_2]
